Picard Medical Shareholders Approve Expanded Capital Stock Authorization

Picard Medical, Inc. ( (PMI) ) has shared an update.

On March 10, 2026, Picard Medical, Inc. stockholders met virtually to vote on key capital structure proposals, with about 57.16% of the 73,701,176 outstanding common shares represented. Investors approved an amendment to increase authorized capital stock from 180,000,000 to 330,000,000 shares, including a doubling of authorized common stock from 150,000,000 to 300,000,000.

Stockholders also approved issuing additional common shares exceeding 20% of the company’s outstanding stock under an existing securities purchase agreement with HT Investments MA LLC and High Trail Special Situations LLC. The approvals expand Picard Medical’s flexibility to raise equity capital, potentially supporting future financing, liquidity, and strategic initiatives, but also setting the stage for increased dilution for existing shareholders.

The most recent analyst rating on (PMI) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Picard Medical, Inc. stock, see the PMI Stock Forecast page.

Spark’s Take on PMI Stock

According to Spark, TipRanks’ AI Analyst, PMI is a Neutral.

The score is held down mainly by very weak fundamentals (large ongoing losses and cash burn) and bearish technicals (below key moving averages with negative MACD). Positive corporate updates and financing improve near-term runway and visibility, but do not yet offset the current profitability and cash-flow risks.

To see Spark’s full report on PMI stock, click here.

More about Picard Medical, Inc.

Picard Medical, Inc. operates in the medical sector, focusing on healthcare-related products and services as a publicly traded company. Its capital structure and equity authorization are key to funding operations and potential growth initiatives in its target markets, with common stock serving as the primary vehicle for shareholder ownership and future financing activities.

Average Trading Volume: 820,412

Technical Sentiment Signal: Strong Sell

For detailed information about PMI stock, go to TipRanks’ Stock Analysis page.